People channel feed – Endpoints News

People channel feed

Dana-Farber chief Laurie Glimcher set to leave storied cancer center

8 months ago

Three Dyne executives leave as company reports new Duchenne drug data

8 months ago

Preclinical team hit hardest in Repare's R&D prioritization, layoffs

8 months ago

BioMarin lays off 225 employees as it cuts spending on gene therapy rollout

8 months ago

Gene editing startup Tome Biosciences to lay off almost all workers

8 months ago

Q&A: GSK CSO Tony Wood on staying out of obesity, 'careful' cancer ambitions, and AI's future in R&D

8 months ago

Updated: Chinese government indicts Japanese Astellas employee for espionage

8 months ago

BioMarin shakes up executive team, tapping notable dealmaker James Sabry

8 months ago

Aadi says its solid tumor drug is unlikely to succeed, winding down the trial and axing staffers

8 months ago

Carbon Health CEO Eren Bali steps down

8 months ago

Q&A: Lykos just cut 75% of its workforce after an FDA rejection. Here’s what the CEO has to say

8 months ago

Esperion's CMO hits the exit; Pfizer appoints Nvidia alum as AI chief

8 months ago

Genentech dissolves cancer immunology group, and research executive Ira Mellman will leave company

8 months ago

Updated: Lykos cutting most of staff less than a week after FDA rejection

8 months ago

Acelyrin sheds pipeline, lays off 33% of staff three months after CEO departure

9 months ago

Lilly opens huge new Boston research center, with a focus on genetic medicines

9 months ago

Lexicon cuts about 75 sales jobs to prep for drug launch early next year

9 months ago

Bill Haney's Dragonfly nabs former Cerevel CFO; Cellectis' new CMO

9 months ago

Infectious disease biotech undergoes makeover after lung disease trial underwhelms

9 months ago

Q&A: PhRMA CEO Stephen Ubl on the IRA, challenges to the FDA’s authority and the US-China relationship

9 months ago

Entero Therapeutics turns the lights off as creditors come calling

9 months ago

Precigen lays off staff, pauses multiple CAR-T programs and all preclinical work and aims for $30M offering

9 months ago

Bicycle Therapeutics focuses pipeline and streamlines leadership team

9 months ago

Exclusive: Covid and epidemic threat biotech Aerium Therapeutics closes after emergence of variants

9 months ago

First page Previous page 6 7 8910 11 12 Next page Last page